Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.04B |
| 2 |
Gaotu Techedu
GOTU
|
+$1.03B |
| 3 |
Visa
V
|
+$749M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$517M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$515M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.43B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.58B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$759M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$643M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.23% |
| 2 | Consumer Discretionary | 8.46% |
| 3 | Healthcare | 7.67% |
| 4 | Financials | 7.46% |
| 5 | Communication Services | 6.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
926
DELISTED
Blueprint Medicines
BPMC
| $63.9M | 0.02% |
569,478
+54,105
| +10% | +$5.7M |
|
927
iShares 1-3 Year Treasury Bond ETF
SHY
$25.1B
| $63.8M | 0.02% |
738,566
+412,901
| +127% | +$35.7M |
|
928
TG Therapeutics
TGTX
$7.46B
| $63.8M | 0.02% |
1,226,427
-50,598
| -4% | -$1.71M |
|
929
Cardinal Health
CAH
$54.7B
| $63.7M | 0.02% |
1,189,033
+133,570
| +13% | +$6.93M |
|
930
Omega Healthcare
OHI
$14.6B
| $63.5M | 0.02% |
1,749,535
-41,882
| -2% | -$1.42M |
|
931
KE Holdings
BEKE
$18.9B
| $63.5M | 0.02% |
1,031,435
+636,941
| +161% | +$42.3M |
|
932
Meritage Homes
MTH
$4.86B
| $63.5M | 0.02% |
1,532,356
-549,718
| -26% | -$26M |
|
933
BJs Wholesale Club
BJ
$12.3B
| $63.4M | 0.02% |
1,700,188
-114,845
| -6% | -$4.59M |
|
|
WORK
934
PUT
DELISTED
Slack Technologies, Inc.
WORK
| $63.4M | 0.02% |
1,500,000
+1,308,800
| +685% | +$44.2M |
|
|
FOE
935
DELISTED
Ferro Corporation
FOE
| $63.2M | 0.02% |
4,319,560
-675,659
| -14% | -$9.38M |
|
936
CONMED
CNMD
$1.51B
| $63.2M | 0.02% |
564,174
+42,519
| +8% | +$4.03M |
|
937
Banner Corp
BANR
$2.44B
| $63.1M | 0.02% |
1,355,159
-154,475
| -10% | -$6.37M |
|
938
Check Point Software Technologies
CHKP
$12.7B
| $63.1M | 0.02% |
474,770
-88,322
| -16% | -$10.8M |
|
939
Zai Lab
ZLAB
$2.09B
| $63.1M | 0.02% |
466,041
-590,183
| -56% | -$60.1M |
|
940
PJT Partners
PJT
$4.38B
| $63M | 0.02% |
837,043
+203,672
| +32% | +$14.3M |
|
941
PUT
Sarepta Therapeutics
SRPT
$1.73B
| $62.9M | 0.02% |
369,200
+33,500
| +10% | +$4.96M |
|
|
MXIM
942
DELISTED
Maxim Integrated Products
MXIM
| $62.9M | 0.02% |
710,018
-2,877,909
| -80% | -$227M |
|
943
CALL
Intel
INTC
$509B
| $62.9M | 0.02% |
1,262,600
+261,600
| +26% | +$12.8M |
|
944
Avery Dennison
AVY
$13.3B
| $62.7M | 0.02% |
404,458
-7,351
| -2% | -$1.06M |
|
945
HSBC
HSBC
$364B
| $62.7M | 0.02% |
2,421,017
+77,462
| +3% | +$1.84M |
|
946
Synopsys
SNPS
$77.3B
| $62.7M | 0.02% |
241,896
-258,187
| -52% | -$59.5M |
|
|
AVNS
947
DELISTED
Avanos Medical
AVNS
| $62.7M | 0.02% |
1,365,961
-85,676
| -6% | -$3.57M |
|
948
Xylem
XYL
$28.5B
| $62.6M | 0.02% |
614,606
-483,205
| -44% | -$45.4M |
|
949
WaFd
WAFD
$2.79B
| $62.5M | 0.02% |
2,429,187
+104,589
| +4% | +$2.49M |
|
950
iShares ESG Aware MSCI USA ETF
ESGU
$18.3B
| $62.5M | 0.02% |
726,644
-129,266
| -15% | -$10.5M |
|
Similar funds
Goldman Sachs's Q4 2020 Portfolio in Review
As of Q4 2020, Goldman Sachs held 5,916 positions worth $389B, up 10% from $352B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Goldman Sachs withdrew a net $17.4B in Q4 2020, closing 466 positions and reducing 2,520 holdings. Its most notable exit was Immunomedics Inc, an estimated $418M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Goldman Sachs opened a new position in Chindata Group Holdings Limited American Depositary Shares worth $290M.
- Goldman Sachs's largest Q4 2020 buy was Chindata Group Holdings Limited American Depositary Shares: 12,107,899 shares worth $290M.
- Goldman Sachs added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2020, an estimated $1.04B increase.
- Goldman Sachs's biggest Q4 2020 reduction was Tesla, cutting an estimated $4.43B.
- Goldman Sachs fully exited Immunomedics Inc in Q4 2020, selling an estimated $418M.
- Goldman Sachs's ten largest holdings make up 20% of its $389B portfolio in Q4 2020.
- Goldman Sachs opened 644 new positions and closed 466 in Q4 2020.
- Goldman Sachs's portfolio value rose 10% quarter-over-quarter to $389B.
Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.